NCT01741727 (Clinical Trial / ABT-414)

Study Title
A Study of ABT-414 in Subjects With Solid Tumors (NCT01741727)

Trial Description
A study of ABT-414 in subjects with solid tumors.

This trial is sponsored by AbbVie.

Study Data

  • Condition: Squamous Cell Tumors
  • Interventions
    • Drugs used in this trial:
      • ABT-414
  • Phase: I
  • Enrollment: 57
  • Start: October 2012
  • Completion: November 2015
  • Last verified: February 2016

Study Schematic

Screen Shot 2016-07-19 at 4.46.42 PM

Return to drug map

Last Editorial review:  July 6, 2016
Information based on ClinicalTrials.gov (NIH/NCI) and other sources.